Investigational Site Number :3800003

Bologna 40138

0 studies enrolling now · 3 studies all time

What they study most

Dermatitis Atopic, Plasma Cell Myeloma

Studies at this site

• Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients — Completed
• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• Observational Evaluation of Atopic Dermatitis in Pediatric Patients — Running, not enrolling